Healthy Returns: Eli Lilly gains momentum against Novo Nordisk in the weight loss drug market

Eli Lilly may be starting to gain an edge over Novo Nordisk in the GLP-1 market. Meanwhile, Stryker will acquire artificial intelligence startup Care.ai.

Aug 15, 2024 - 04:00

0 4

Healthy Returns: Eli Lilly gains momentum against Novo Nordisk in the weight loss drug market

Eli Lilly may be starting to gain an edge over Novo Nordisk in the GLP-1 market. Meanwhile, Stryker will acquire artificial intelligence startup Care.ai.

Tags:

Previous Article

Here's the inflation breakdown for July 2024 — in one chart

A U.S. construction boom is sending rents lower and creating perks for renters

admin

admin

This website uses cookies to enhance your browsing experience. By continuing to use this site, you consent to the use of cookies. Please review our Privacy Policy for more information on how we handle your data.